Insights
Insights From Our Experts
Articles
Think Tank 2025 Pharma Forecast: What Lies Ahead for the Industry in 2025?
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of emerging technologies, regulatory shifts, personalized medicine, and lessons from recent global crises. Together, these trends will redefine the pharmaceutical landscape,…
Evaluating PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Matching-Adjusted Indirect Comparison
Posted by
Imtiaz Samjoo , Anja Haltner, MSc , Samantha Craigie , Di Wang , Sarah Walsh on December 19, 202412/19/24
Metastatic castration-resistant prostate cancer (mCRPC) is an incurable condition associated with poor prognosis and quality of life. Historically, patients with mCRPC had limited therapeutic options, and despite advancements in therapeutic innovation, the five-year relative survival rate…
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services
Patients today too often find themselves navigating a myriad of challenges that can make accessing quality healthcare a daunting task. Various common obstacles range from financial barriers to long wait times, to geographical and technological limitations…
Association Between Targeted Therapy and Survival in Patients with Myelodysplastic Syndromes
Posted by
Pierantonio Russo, MD, FCPP, FAAP, STS , Ramaa Nathan, PhD , Alex Moore, PhD , Daniel Pfeffer, PhD on December 10, 202412/10/24
Precision oncology offers a new approach to cancer care by providing targeted treatments for patients with actionable genetic mutations. However, in the U.S., nearly one-third of eligible patients face barriers such as delayed test results, limited…
Association Between Targeted Therapy and Survival in Patients With Acute Myeloid Leukemia
Posted by
Pierantonio Russo, MD, FCPP, FAAP, STS , Ramaa Nathan, PhD , Alex Moore, PhD , Daniel Pfeffer, PhD on December 9, 202412/9/24
Precision oncology innovatively addresses cancer care by targeting treatments to patients with specific biomarker alterations. However, in the U.S., nearly one-third of eligible patients miss out on these life-saving therapies. Operational barriers, physician awareness gaps, slow…
Successfully Navigating Global Commercialization- A View from the C-Suite and Global Commercial Leaders
Launching in today’s unpredictable market is a journey with new challenges around every corner. While product pipelines are rapidly growing, stringent competition and an evolving provider environment are putting intense pressure on manufacturers to build…
Insight from Frontiers Health: Harnessing Machine Learning to Transform Clinical Outcomes
Our Chief Medical Officer, Dr. Pierantonio Russo, joined on stage at Frontiers Health 2024 to discuss the impact of Machine Learning (ML) on healthcare, particularly in predicting hospital readmissions and managing chronic diseases. In this session,…
The Promise of Direct-to-Patient – What’s Really Needed for Patient Access
In today’s healthcare landscape, patients are no longer passive recipients of care. They are empowered, tech-savvy stakeholders who demand efficiency and transparency. Yet, despite advancements in consumer innovation, the healthcare system often leaves them frustrated with…
The Importance of Quality-of-Life Metrics in mCRPC
Posted by
Rhett Figliuzzi , Samantha Craigie , Sarah Walsh , Imtiaz Samjoo on November 26, 202411/26/24
Prostate cancer is one of the most diagnosed malignancies in the world, with many patients progressing to an advanced stage of the disease called metastatic castration-resistant prostate cancer (mCRPC). Due to the poor prognosis and incurable…
The Increasing Role of AI in Improving the Diagnostic Imaging Landscape
Discover how artificial intelligence is revolutionizing the medical imaging landscape in our latest white paper, “The Increasing Role of AI in Improving the Diagnostic Imaging Landscape.” This comprehensive guide explores: Enhanced Diagnostic Accuracy: Learn how AI…